Veru's Phase 2b study shows enobosarm combined with semaglutide improves safety, reduces gastrointestinal issues, and promotes fat loss while preserving lean mass. There is a potential risk that ...

Hyderabad Airport Metro Limited (HAML) has informed that the Detailed Project Reports (DPRs) of the proposed Phase 2B of Hyderabad Metro Rail for JBS-Medchal, JBS-Shameerpet, and Airport - Future ...

Leo Pharma has shared phase 2b data on its eczema prospect temtokibart, reporting that the top three doses of the IL-22RA1 blocker beat placebo on the primary endpoint. Temtokibart is designed to ...

Veru Inc. updates on its Phase 2b clinical trials ... the Company plans to partner with the Colorado Prevention Center, Aurora, Colorado and Lundquist Institute, Torrence, California.

CORPUS CHRISTI, Texas — The Corpus Christi Fire Department is moving ahead with phase two of its Resource Center project, with a clear focus: protecting equipment and supporting firefighter ...

Get ready for an unforgettable night of music and energy as FELIP takes the stage live at the Ayala Center Cebu Activity Center on April 11, 2025 (Friday), at 7:00 PM. Don’t miss this chance to ...

OST-HER2 demonstrated positive data in a Phase 2b clinical trial of OST-HER2 in ... visit our privacy center. Maintaining independence and editorial freedom is essential to our mission of ...

President Bola Tinubu has flagged off the 2B access road to the second Niger Bridge in Onitsha, Anambra state. The N170 .7bn contract was awarded to CGC construction company for completion within ...

Lexicon (LXRX) Pharmaceuticals announced topline results from the PROGRESS Phase 2b study evaluating pilavapadin, an oral, non-opioid investigational adaptor-associated kinase 1 inhibitor in adult ...

Phase 2b data show OST-HER2 significantly improved ... programs and related intellectual property (IP) assets from Ayala Pharmaceuticals. OS Therapies will pay $0.5 million in cash and issue ...

The company announced positive top-line results from the Phase 2b QUALITY study for enobosarm, which demonstrated a 71% relative reduction in lean mass loss in patients receiving enobosarm and ...